Package 69729-070-06

{"route": ["ORAL"], "spl_id": "2860afb9-3da9-5f80-e063-6394a90ab76b", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "upc": ["0810053180525"], "unii": ["362O9ITL9D", "9D2RTI9KYH", "495W7451VQ", "04JA59TNSJ"], "rxcui": ["1790651"], "spl_set_id": ["05cd9513-1a42-e990-e063-6294a90a57df"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["OPMX LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (69729-070-06)  / 177 mL in 1 BOTTLE, PLASTIC", "package_ndc": "69729-070-06", "marketing_start_date": "20230918"}], "brand_name": "Tenalif Children", "product_id": "69729-070_2860afb9-3da9-5f80-e063-6394a90ab76b", "dosage_form": "SYRUP", "pharm_class": ["Adrenergic alpha1-Agonists [MoA]", "Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]", "Sigma-1 Agonist [EPC]", "Sigma-1 Receptor Agonists [MoA]", "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]", "Uncompetitive NMDA Receptor Antagonists [MoA]", "alpha-1 Adrenergic Agonist [EPC]"], "product_ndc": "69729-070", "generic_name": "Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl", "labeler_name": "OPMX LLC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Tenalif Children", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/10mL"}, {"name": "DEXTROMETHORPHAN HYDROBROMIDE", "strength": "13.33 mg/10mL"}, {"name": "GUAIFENESIN", "strength": "200 mg/10mL"}, {"name": "PHENYLEPHRINE HYDROCHLORIDE", "strength": "5 mg/10mL"}], "application_number": "M012", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20230918", "listing_expiration_date": "20261231"}